Doberstein Stephen K Insider Trades

Insider Trading History

Track insider trading activity for Doberstein Stephen K. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Forte Biosciences
Forte Biosciences FBRX
Director
Holding Value $793k 18,353 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$350k 18,353 shares
$19.07
$43.20
Forte Biosciences
Forte Biosciences FBRX
Director
Holding Value $1.34M 31,000 shares
Last Trade
Mar 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$234k 31,000 shares
$7.54
$43.20
Forte Biosciences
Forte Biosciences FBRX
Director
Holding Value $2.16M 50,000 shares
Last Trade
Aug 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$413k 50,000 shares
$8.25
$43.20
Forte Biosciences
Forte Biosciences FBRX
Director
Holding Value $1.08M 25,000 shares
Last Trade
Sep 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$500k 25,000 shares
$20.00
$43.20
Forte Biosciences
Forte Biosciences FBRX
Director
Holding Value $1.08M 25,000 shares
Last Trade
Jun 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$794k 25,000 shares
$31.75
$43.20
Forte Biosciences
Forte Biosciences FBRX
Director
Holding Value $2.16M 50,000 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.48M 50,000 shares
$29.50
$43.20
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Director
Holding Value $0 0 shares
Last Trade
Dec 28, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.23M 58,333 shares
$38.22
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Director
Holding Value $0 0 shares
Last Trade
Dec 28, 2021 Sale (Tender)Reported as Tender on SEC Form 4.
$127k 3,333 shares
$38.25
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Director
Holding Value $127k 3,333 shares
Last Trade
Jun 03, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$102k 3,333 shares
$30.47
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Director
Holding Value $0 0 shares
Last Trade
Jun 03, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$102k 3,333 shares
$30.47
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Director
Holding Value $573k 15,000 shares
Last Trade
Jun 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$559k 18,333 shares
$30.47
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Director
Holding Value $573k 15,000 shares
Last Trade
Jun 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$396k 18,333 shares
$21.61
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Director
Holding Value $956k 25,000 shares
Last Trade
Mar 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$390k 25,000 shares
$15.61
$38.22
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Scientific Officer
Holding Value $7.23M 107,668 shares
Last Trade
Sep 05, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$259k 15,000 shares
$17.28
$67.17
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Scientific Officer
Holding Value $6.22M 92,668 shares
Last Trade
Aug 16, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$58.9k 3,245 shares
$18.15
$67.17
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Scientific Officer
Holding Value $6.44M 95,913 shares
Last Trade
May 16, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$109k 3,461 shares
$31.37
$67.17
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Scientific Officer
Holding Value $6.67M 99,374 shares
Last Trade
Feb 19, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$140k 3,310 shares
$42.39
$67.17
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Scientific Officer
Holding Value $6.9M 102,684 shares
Last Trade
Dec 14, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.64M 72,350 shares
$36.51
$67.17
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Scientific Officer
Holding Value $5.29M 78,734 shares
Last Trade
Nov 16, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$173k 4,524 shares
$38.25
$67.17
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Scientific Officer
Holding Value $5.59M 83,258 shares
Last Trade
Aug 16, 2018 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$391k 6,701 shares
$58.40
$67.17

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up